Osborne Clarke advises finnCap on placing for Synairgen to accelerate potential COVID-19 treatment trial
International legal practice Osborne Clarke has advised finnCap Ltd on the successful £14 million placing for AIM-quoted Synairgen plc, the...
Published on
25/03/2020
Read time
1m